0
0
0
s2sdefault

World's No.2 cigarette company British American Tobacco said on Friday it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.

The maker of Lucky Strike cigarette said once it gets approval from the U.S. Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.